WDR4
Basic information
Region (hg38): 21:42843094-42879568
Links
Phenotypes
GenCC
Source:
- Galloway-Mowat syndrome 6 (Limited), mode of inheritance: AR
- Galloway-Mowat syndrome (Supportive), mode of inheritance: AR
- microcephaly, growth deficiency, seizures, and brain malformations (Moderate), mode of inheritance: AR
- microcephaly, growth deficiency, seizures, and brain malformations (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Galloway-Mowat syndrome 6 | AR | Endocrine; Renal | Endocrine manifestations such as growth hormone deficiency have been observed, and awareness may allow prompt recognition and treatment; Among other features, the condition may include renal disease, and use of immunosuppressive treatments has been described as necessary in at least one patient | Craniofacial; Endocrine; Neurologic; Renal | 26416026; 28617965; 29597095; 30079490 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (199 variants)
- Inborn_genetic_diseases (107 variants)
- WDR4-related_disorder (28 variants)
- Galloway-Mowat_syndrome_6 (14 variants)
- Microcephaly,_growth_deficiency,_seizures,_and_brain_malformations (8 variants)
- not_specified (3 variants)
- Galloway-Mowat_syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDR4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018669.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 64 | 69 | ||||
missense | 118 | 18 | 141 | |||
nonsense | 3 | |||||
start loss | 1 | 1 | 2 | |||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 8 | 9 | 121 | 82 | 5 |
Highest pathogenic variant AF is 0.0000136395
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WDR4 | protein_coding | protein_coding | ENST00000398208 | 11 | 36475 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.38e-8 | 0.595 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.02 | 304 | 258 | 1.18 | 0.0000165 | 2636 |
Missense in Polyphen | 64 | 60.167 | 1.0637 | 695 | ||
Synonymous | -1.47 | 134 | 114 | 1.18 | 0.00000807 | 808 |
Loss of Function | 1.16 | 15 | 20.7 | 0.725 | 9.73e-7 | 219 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000263 | 0.000243 |
Ashkenazi Jewish | 0.000399 | 0.000397 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000108 | 0.0000967 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000171 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for the formation of N(7)-methylguanine at position 46 (m7G46) in tRNA. In the complex, it is required to stabilize and induce conformational changes of the catalytic subunit. {ECO:0000255|HAMAP-Rule:MF_03056, ECO:0000269|PubMed:12403464}.;
- Pathway
- tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.820
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.72
Haploinsufficiency Scores
- pHI
- 0.840
- hipred
- N
- hipred_score
- 0.200
- ghis
- 0.614
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.939
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wdr4
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- tRNA modification;tRNA (guanine-N7)-methylation
- Cellular component
- nucleus;nucleoplasm;cytosol;tRNA methyltransferase complex
- Molecular function
- protein binding;tRNA (guanine-N7-)-methyltransferase activity